日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma

FLIPI24:一种用于新诊断滤泡性淋巴瘤的现代预后模型和临床试验富集工具

Maurer, Matthew J; Prochazka, Vit K; El-Galaly, Tarec Christoffer; Flowers, Christopher R; Villa, Diego; Bachy, Emmanuel; Cahn, Elliot J; Fournier, Marguerite; Larson, Melissa C; Dietrich, Caroline E; Jakobsen, Lasse Hjort; Ghesquières, Hervé; Kridel, Robert; Gandhi, Maher K; Cheah, Chan Y; Hawkes, Eliza A; Seymour, John F; Freeman, Ciara L; Clausen, Michael R; Wahlin, Björn E; Friedberg, Jonathan W; Casulo, Carla; Habermann, Thomas M; Wang, Yucai; Nastoupil, Loretta J; de Nully Brown, Peter; Belada, David; Janíková, Andrea; Mocikova, Heidi; Fürst, Tomáš; Feugier, Pierre; Tilly, Hervé; Haioun, Corinne; Davies, Andrew J; Cartron, Guillaume; Burack, Richard; Chihara, Dai; Martin, Peter; Cohen, Jonathon B; Lossos, Izidore S; Kahl, Brad S; Sehn, Laurie H; Smedby, Karin E; Salles, Gilles; Trneny, Marek; Link, Brian K; Morschhauser, Franck; Cerhan, James R

Cytopenias and infections following ciltacabtagene autoleucel in heavily pretreated relapsed or refractory multiple myeloma

在接受过大量预处理的复发或难治性多发性骨髓瘤患者中,使用ciltacabtagene autoleucel治疗后出现细胞减少症和感染

Dima, Danai; Logue, Jennifer M; Waqar, Syed Hamza Bin; Peres, Lauren C; Colin-Leitzinger, Christelle M; De Avila, Gabriel; Smith, Eric C; Skelson, Lawrence; Matte, Kristy L; Blue, Brandon; Hovanky, Vanna N; Gaballa, Mahmoud; Pasvolsky, Oren; Oswald, Laura B; Fortuna, Gliceida Galarza M; Wagner, Charlotte B; DeJarnette, Shaun; Dillard, Christen; Perna, Fabiana; Mikkilineni, Lekha; Hosoya, Hitomi; Freeman, Ciara L; Shain, Kenneth H; Baz, Rachid C; Grajales-Cruz, Ariel; Puglianini, Omar Castaneda; Alsina, Melissa; Locke, Frederick L; Shune, Leyla O; Sborov, Douglas W; Patel, Krina K; Sidana, Surbhi; Hansen, Doris K

Population-wide introduction of dose-adjusted EPOCH-R in high-grade B-cell lymphoma with MYC/BCL2 rearrangements, DLBCL morphology

在具有 MYC/BCL2 重排的高级别 B 细胞淋巴瘤、DLBCL 形态学中,广泛推广剂量调整后的 EPOCH-R 方案

Alduaij, Waleed; Sehn, Laurie H; Champagne, Jean-Nicolas; Collinge, Brett; Ben-Neriah, Susana; Jiang, Aixiang; Hilton, Laura K; Boyle, Merrill; Meissner, Barbara; Slack, Graham W; Farinha, Pedro; Craig, Jeffrey W; Savage, Kerry J; Villa, Diego; Gerrie, Alina S; Freeman, Ciara L; Mungall, Andrew J; Steidl, Christian; Scott, David W

Meaningful change in patient-reported outcomes after CAR-T for multiple myeloma: differences by race and ethnicity

CAR-T疗法治疗多发性骨髓瘤后,患者报告结局发生显著变化:种族和民族差异

Oswald, Laura B; Li, Xiaoyin; Ferraris, Carina E; De Avila, Gabe; Scheiber-Camoretti, David; Gudenkauf, Lisa M; Small, Brent J; Gonzalez, Brian D; Hoogland, Aasha I; Nguyen, Oanh; Rodriguez, Yvelise; Crowder, Sylvia L; Parker, Nathan; Carson, Tiffany L; Vinci, Christine E; Baz, Rachid C; Shain, Kenneth H; Blue, Brandon; Grajales-Cruz, Ariel F; Matte, Kristy; Kale, Brandon; Kaldas, David; Perna, Fabiana; Alsina, Melissa; Freeman, Ciara L; Castaneda Puglianini, Omar; Nishihori, Taiga; Liu, Hien; Locke, Frederick L; Jim, Heather S L; Hansen, Doris K; Peres, Lauren C

Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma

复发/难治性多发性骨髓瘤标准治疗方案 Idecabtagene Vicleucel 与 Ciltacabtagene Autoleucel 的比较

Hansen, Doris K; Peres, Lauren C; Dima, Danai; Richards, Alicia; Shune, Leyla; Afrough, Aimaz; Midha, Shonali; Dhakal, Binod; Kocoglu, Mehmet H; Atrash, Shebli; Ferreri, Christopher; Castaneda, Omar; Davis, James A; Bhurtel, Evguenia; McGuirk, Joseph; Wagner, Charlotte; Bansal, Radhika; Costello, Patrick; Smith, Kinaya; Lieberman-Cribbin, Alex; De Avila, Gabriel; Purvey, Sneha; Hosoya, Hitomi; Mikkilineni, Lekha; Oswald, Laura B; Kaur, Gurbakhash; Pasvolsky, Oren; Gaballa, Mahmoud; Herr, Megan M; Forsberg, Peter; Janakiram, Murali; Htut, Myo; Asoori Maringanti, Sireesha; Kalariya, Nilesh; Hashmi, Hamza; Reshef, Ran; Sborov, Douglas W; Nadeem, Omar; Anwer, Faiz; Khouri, Jack; Raza, Shahzad; Atanackovic, Djordje; Alsina, Melissa; Freeman, Ciara L; Locke, Frederick L; Voorhees, Peter; Anderson, Larry D Jr; Richard, Shambavi; Martin, Thomas; Lin, Yi; Patel, Krina K; Sidana, Surbhi

Standard-of-care idecabtagene vicleucel for relapsed/refractory multiple myeloma

复发/难治性多发性骨髓瘤的标准治疗方案idecabtagene vicleucel

Sidana, Surbhi; Ahmed, Nausheen; Akhtar, Othman Salim; Brazauskas, Ruta; Oloyede, Temitope; Bye, Matthew; Hansen, Doris; Ferreri, Christopher; Freeman, Ciara L; Afrough, Aimaz; Anderson, Larry D Jr; Dhakal, Binod; Dhanda, Devender; Gowda, Lohith; Hashmi, Hamza; Harrison, Melanie J; Kitali, Amani; Landau, Heather; Mirza, Abu-Sayeef; Patwardhan, Pallavi; Qazilbash, Muzaffar; Usmani, Saad; Patel, Krina; Nishihori, Taiga; Ganguly, Siddhartha; Pasquini, Marcelo C

Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma

标准疗法 ciltacabtagene autoleucel 治疗复发/难治性多发性骨髓瘤的安全性和有效性

Sidana, Surbhi; Patel, Krina K; Peres, Lauren C; Bansal, Radhika; Kocoglu, Mehmet H; Shune, Leyla; Atrash, Shebli; Smith, Kinaya; Midha, Shonali; Ferreri, Christopher; Dhakal, Binod; Dima, Danai; Costello, Patrick; Wagner, Charlotte; Reshef, Ran; Hosoya, Hitomi; Mikkilineni, Lekha; Atanackovic, Djordje; Chhabra, Saurabh; Parrondo, Ricardo; Nadeem, Omar; Mann, Hashim; Kalariya, Nilesh; Hovanky, Vanna; De Avila, Gabriel; Freeman, Ciara L; Locke, Frederick L; Alsina, Melissa; Wong, Sandy; Herr, Megan; Htut, Myo; McGuirk, Joseph; Sborov, Douglas W; Khouri, Jack; Martin, Thomas; Janakiram, Murali; Lin, Yi; Hansen, Doris K

Urine-free response criteria predict progression-free survival in multiple myeloma: a post hoc analysis of BMT CTN 0702

尿液无反应标准预测多发性骨髓瘤的无进展生存期:BMT CTN 0702 的事后分析

Banerjee, Rahul; Fritz, Amber R; Akhtar, Othman S; Freeman, Ciara L; Cowan, Andrew J; Shah, Nina; Landau, Heather J; Kumar, Shaji K; Vogl, Dan T; Efebera, Yvonne A; McCarthy, Philip L; Vesole, David H; Mendizabal, Adam; Krishnan, Amrita Y; Somlo, George; Stadtmauer, Edward A; Pasquini, Marcelo C

Enhanced CAR-T cell function and mitochondrial fitness from earlier unfractionated stem cell product in multiple myeloma.

在多发性骨髓瘤中,来自早期未分选干细胞产品的 CAR-T 细胞功能和线粒体适应性得到增强

Freeman Ciara L, Abraham-Miranda Julieta, Menges Meghan, Atkins Reginald M, Noble Jerald, Liu Hien, Corallo Salvatore, Cuadrado Delgado Luis A, Ribickas Albert J, Savid-Frontera Constanza, de Avila Gabriel, Castaneda Puglianini Omar A, Ochoa-Bayona Jose, Hansen Doris K, Alsina Melissa, Baz Rachid, Nishihori Taiga, Shain Kenneth H, Locke Frederick L

Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma

多发性骨髓瘤患者接受 CAR-T 疗法后,超过 4 周的普遍驾驶限制似乎没有必要。

Banerjee, Rahul; Richards, Alicia; Midha, Shonali; Afrough, Aimaz; Anwer, Faiz; Atanackovic, Djordje; Atrash, Shebli; Bachanova, Veronika; Beitinjaneh, Amer M; Bhurtel, Evguenia; Castaneda Puglianini, Omar; Chhabra, Saurabh; Cicero, Kara I; Davis, James A; Dhakal, Binod; Dima, Danai; Ferreri, Christopher J; Forsberg, Peter A; Freeman, Ciara L; Herr, Megan M; Jain, Tania; Janakiram, Murali; Khouri, Jack; Kocoglu, Mehmet H; Kumar, Anupama; Liu, Yuxin; Locke, Frederick; McGuirk, Joseph P; Mikkilineni, Lekha; Nadeem, Omar; Parrondo, Ricardo D; Pasvolsky, Oren; Peres, Lauren C; Purvey, Sneha; Raza, Shahzad; Reshef, Ran; Richard, Shambavi; Rossi, Adriana C; Sborov, Douglas W; Shune, Leyla; Wagner, Charlotte B; Zanwar, Saurabh S; Sidana, Surbhi; Patel, Krina K; Hansen, Doris K; Kumar, Shaji K; Lin, Yi; Martin, Thomas G; Voorhees, Peter M; Anderson, Larry D Jr; Cowan, Andrew J; Kaur, Gurbakhash